Folger Nolan Fleming Douglas Capital Management, Inc Abbott Laboratories Transaction History
Folger Nolan Fleming Douglas Capital Management, Inc
- $817 Million
- Q1 2025
A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 96,452 shares of ABT stock, worth $12.9 Million. This represents 1.57% of its overall portfolio holdings.
Number of Shares
96,452
Previous 97,567
1.14%
Holding current value
$12.9 Million
Previous $11 Million
15.94%
% of portfolio
1.57%
Previous 1.26%
Shares
33 transactions
Others Institutions Holding ABT
# of Institutions
3,541Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.5 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.93 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.78 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $234B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...